医学
肺动脉高压
重症监护医学
心脏病学
内科学
血流动力学
临床试验
作者
Hossein Ardeschir Ghofrani,Martin W. Wilkins,Stuart Rich
出处
期刊:Circulation
[Ovid Technologies (Wolters Kluwer)]
日期:2008-09-09
卷期号:118 (11): 1195-1201
被引量:89
标识
DOI:10.1161/circulationaha.106.674002
摘要
The availability of new treatments for patients with pulmonary arterial hypertension has increased awareness and interest in the medical community for pulmonary vascular diseases in general. Many uncertainties exist, however, regarding the diagnosis and treatment of patients with pulmonary arterial hypertension that are particularly pertinent for the management of patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with underlying diseases. This review highlights controversial issues around the definition and diagnosis of pulmonary hypertension, the interpretation of hemodynamic variables, and the interpretation of clinical responsiveness to chronic therapies. In addition, we propose guidelines applicable to the conduct of new therapeutic trials in pulmonary arterial hypertension, which aim to provide greater confidence in the efficacy and safety of new treatments currently under development.
科研通智能强力驱动
Strongly Powered by AbleSci AI